GE LIFE SCIENCES acquired by DANAHER
Context
Danaher has finalized an agreement to acquire GE Biopharma in a transformational all-cash transaction, an operation designed to fundamentally redefine the landscape of the global bioprocessing market. The strategic rationale for this transaction centers on a "Bioprocessing-Powerhouse" play, merging the target's industry-leading technical operational depth in chromatography and cell culture with the group’s established life sciences platform and the power of the Danaher Business System. This structural alignment provides the organization with the scientific talent and technological hardware—specifically across upstream and downstream workflows—required to address the surging global demand for biologic drug development.
GE LIFE SCIENCES, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Industry & Manufacturing sector (11.7x).
-> Deep-dive in Industry & Manufacturing market trends
Target
GE Biopharma is a USA company specialized in Bioprocessing & Cell Analysis. They have built a distinct space in the healthcare market as the primary provider of the "industrial plumbing" required for the discovery and manufacturing of biologic drugs. Instead of just selling laboratory equipment, they thrive on a philosophy of technical operational depth, providing the essential chromatography hardware, cell culture media, and single-use technologies that allow pharmaceutical companies to scale their innovations. What makes them a go-to partner is their integrated software and consumables model, which ensures that 75% of their revenue is recurring. Their roadmap is centered on enabling the proliferation of complex cell and gene therapies through advanced upstream and downstream processing solutions.
Ent. Value
$20–50bn
Equity Value
[members only]
Multiples
EV / Revenue
4x–10x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Industrial Equipment
Similar deals in Industrial Equipment
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 08/2019 | TELEDYNE TECHNOLOGIES INCORPORATED | 3M GAS AND FLAME DETECTION | FRANCE | Instrumentation & Measurement |
| 08/2019 | AGILENT TECHNOLOGIES | BIOTEK INSTRUMENTS | UNITED STATES | Lab & Scientific Equipment |
| 01/2019 | ARDIAN | CELLI GROUP | ITALY | Food & Beverage Lines |
| 12/2018 | HITACHI | ABB Power Grids | SWITZERLAND | Electrical Equipment |
| 09/2018 | GROUPE ATLANTIC | ACV | BELGIUM | Boilers & Thermal Solutions |
| 07/2018 | WEIR GROUP | ESCO CORPORATION | UNITED STATES | Special Machinery |
| 07/2018 | MAREL | MAJA | GERMANY | Food & Beverage Lines |
| 07/2018 | ARDIAN | COROB | ITALY | Special Machinery |
| 07/2018 | TSINGHUA UNIGROUP | LINXENS | FRANCE | Safety & Security |
| 06/2018 | CDPQ - CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | Delachaux | FRANCE | Components |
Other operations with DANAHER
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 08/2023 | DANAHER | ABCAM | UNITED KINGDOM | Instrumentation & Measurement |
REFERENCES
Valuation range: EV $20–50bn
Revenue range: $1–10bn
EBITDA range: $1–10bn
EV/Revenue range: 4x - 10x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GE LIFE SCIENCES by DANAHER are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: danaher